[go: up one dir, main page]

BG50278A3 - Метод за получаване на (1н-азол-1-илметил)-заместени бензотриазолови производни - Google Patents

Метод за получаване на (1н-азол-1-илметил)-заместени бензотриазолови производни

Info

Publication number
BG50278A3
BG50278A3 BG084328A BG8432888A BG50278A3 BG 50278 A3 BG50278 A3 BG 50278A3 BG 084328 A BG084328 A BG 084328A BG 8432888 A BG8432888 A BG 8432888A BG 50278 A3 BG50278 A3 BG 50278A3
Authority
BG
Bulgaria
Prior art keywords
azole
preparation
benzotriazole derivatives
ilmethyl
substituted benzotriazole
Prior art date
Application number
BG084328A
Other languages
English (en)
Inventor
Alfons Herman Raeymaekers
Eddy Jean Freyne
Josephus Ludovicus Huber Gelder
Marc Venet
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of BG50278A3 publication Critical patent/BG50278A3/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Бензотриазоловите производни се използват във фармацията за лечение на болести у бозайници, причинени от хормона естроген. Методът за получаване на (1н-азол-1-илметил) заместени бензотриазолови производни с обща формуласе състои в това, че азол с формулаили негова алкалнометална сол се n-алкилира с бензотриазол с формула1 претенция
BG084328A 1987-06-01 1988-05-31 Метод за получаване на (1н-азол-1-илметил)-заместени бензотриазолови производни BG50278A3 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5602187A 1987-06-01 1987-06-01

Publications (1)

Publication Number Publication Date
BG50278A3 true BG50278A3 (bg) 1992-06-15

Family

ID=22001654

Family Applications (2)

Application Number Title Priority Date Filing Date
BG084328A BG50278A3 (bg) 1987-06-01 1988-05-31 Метод за получаване на (1н-азол-1-илметил)-заместени бензотриазолови производни
BG098159A BG60429B2 (bg) 1987-06-01 1993-10-18 (1н-азол-1-илметил)заместени бензотриазолни производни

Family Applications After (1)

Application Number Title Priority Date Filing Date
BG098159A BG60429B2 (bg) 1987-06-01 1993-10-18 (1н-азол-1-илметил)заместени бензотриазолни производни

Country Status (24)

Country Link
EP (1) EP0293978B1 (bg)
JP (1) JPH0662612B2 (bg)
KR (1) KR970000952B1 (bg)
CN (1) CN1022184C (bg)
AU (1) AU603446B2 (bg)
BG (2) BG50278A3 (bg)
CA (1) CA1307271C (bg)
CY (1) CY1866A (bg)
DE (1) DE3884055T2 (bg)
DK (1) DK175218B1 (bg)
ES (1) ES2059490T3 (bg)
FI (1) FI90078C (bg)
HK (1) HK114795A (bg)
HU (2) HU201056B (bg)
IE (1) IE61823B1 (bg)
IL (1) IL86551A (bg)
LT (1) LT3950B (bg)
LV (1) LV10452B (bg)
NO (1) NO169900C (bg)
NZ (1) NZ224714A (bg)
PT (1) PT87623B (bg)
RU (1) RU1838308C (bg)
UA (1) UA11192A (bg)
ZA (1) ZA883861B (bg)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8827820D0 (en) * 1988-11-29 1988-12-29 Janssen Pharmaceutica Nv (1h-azol-1-ylmethyl)substituted quinoline derivatives
CA2002859C (en) * 1988-11-29 1998-12-29 Jean P. F. Van Wauwe Method of treating epithelial disorders
US5157046A (en) * 1988-11-29 1992-10-20 Janssen Pharmaceutica N.V. Method of treating epithelial disorders
EP0408509B1 (de) * 1989-07-14 1996-03-06 Ciba-Geigy Ag Substituierte Benzonitrile
US5066656A (en) * 1989-11-01 1991-11-19 Janssen Pharmaceutica N.V. Pharmacologically active (6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1H-benzotriazole derivatives
CA2026792A1 (en) * 1989-11-01 1991-05-02 Michael N. Greco (6,7-dihydro-5h-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1h-benzotriazole derivatives
NZ236440A (en) * 1989-12-15 1993-07-27 Merck & Co Inc Reversal of sexual phenotype in poultry using an inhibitor of steroid biotransformation and/or aromatase inhibitor, poultry produced by this process
AU7124691A (en) * 1990-02-27 1991-08-29 Ciba-Geigy Ag Benzofurans
DE4010797A1 (de) * 1990-04-04 1991-10-10 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung
EP0457716A1 (de) * 1990-04-20 1991-11-21 Ciba-Geigy Ag Naphthalinderivate
TW224461B (bg) * 1990-09-18 1994-06-01 Ciba Geigy Ag
US5162337A (en) * 1990-10-05 1992-11-10 Merck & Co., Inc. Animal growth promotion
TW210334B (bg) * 1990-12-12 1993-08-01 Ciba Geigy Ag
CH683151A5 (de) * 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
CA2116773C (en) 1991-09-02 2002-12-10 Minoru Okada Triazolylated tertiary amine compound or salt thereof
US5635521A (en) * 1991-09-23 1997-06-03 Sandoz Ltd. Imidazolylmethyl-pyridines
JP2700595B2 (ja) * 1992-05-21 1998-01-21 呉羽化学工業株式会社 アゾール誘導体を含有する抗アロマターゼ剤
CA2148489A1 (en) * 1992-11-10 1994-05-26 Albert Louis Anna Willemsens Process for preparing enantiomerically pure 6-¬(4-chlorophenyl)(1h-1,2,4-triazol-1-yl) methyl|-1-methyl-1h
CA2150326A1 (en) * 1994-05-27 1995-11-28 Kimihiro Murakami Azolyl methyl phenyl derivatives having aromatase inhibitory activity
AU6821196A (en) * 1995-08-14 1997-03-12 Janssen Pharmaceutica N.V. Transdermal administration of vorozole
IT1286866B1 (it) * 1996-10-28 1998-07-17 Menarini Farma Ind Composti furano-eterociclici,loro preparazione ed uso come inibitori di aromatasi
EP0949242A4 (en) * 1996-12-24 2004-09-08 Chugai Seiyakukabushiki Kaisha AROMATIC AMINE DERIVATIVES HAVING AN INHIBITORY ACTION WITH RESPECT TO OUR
AU2001264223A1 (en) * 2000-06-28 2002-01-08 Ssp Co., Ltd. Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts
CA2517517C (en) * 2003-03-03 2012-12-18 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
US7135575B2 (en) 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
US20090036435A1 (en) 2005-01-21 2009-02-05 Astex Therapeutics Limited Pharmaceutical Compounds
JP5137816B2 (ja) * 2005-04-29 2013-02-06 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ カンナビノイド受容体アンタゴニストとしてのベンゾトリアゾール誘導体
US7572807B2 (en) 2005-06-09 2009-08-11 Bristol-Myers Squibb Company Heteroaryl 11-beta-hydroxysteroid dehydrogenase type I inhibitors
US8361996B2 (en) 2005-09-15 2013-01-29 Council Of Scientific And Industrial Research Imidazolyl substituted steroidal and indan-1-one derivatives
BRPI0707401B8 (pt) 2006-01-31 2022-12-20 Array Biopharma Inc compostos inibidores de cinase, composição farmacêutica, processo para a preparação e usos dos referidos compostos ou de um pró-fármaco de um composto
US8883790B2 (en) 2006-10-12 2014-11-11 Astex Therapeutics Limited Pharmaceutical combinations
EP2073803B1 (en) 2006-10-12 2018-09-19 Astex Therapeutics Limited Pharmaceutical combinations
WO2012052540A1 (en) * 2010-10-21 2012-04-26 Universitaet Des Saarlandes Selective cyp11b1 inhibitors for the treatment of cortisol dependent diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR75101B (bg) * 1980-10-23 1984-07-13 Pfizer
US4659730A (en) * 1984-06-18 1987-04-21 Eli Lilly And Company Aromatase inhibiting imidazole derivatives
US4609666A (en) * 1984-06-18 1986-09-02 Eli Lilly And Company Aromatase inhibiting derivatives of α,α-bis(4-halophenyl)methyltetrazoles and triazoles
US4801594A (en) * 1984-06-18 1989-01-31 Eli Lilly And Company Aromatase inhibitors
US4602025A (en) * 1984-06-18 1986-07-22 Eli Lilly And Company Aromatase inhibitors
EP0165781A1 (en) * 1984-06-18 1985-12-27 Eli Lilly And Company Aromatase inhibiting N-substituted imidazole derivatives
DE3744589C1 (de) 1987-12-31 1988-12-29 Albrecht Josef Bohrfutter Nachspannendes Bohrfutter

Also Published As

Publication number Publication date
UA11192A (uk) 1996-12-25
DE3884055D1 (de) 1993-10-21
AU1653788A (en) 1988-12-01
DK175218B1 (da) 2004-07-12
IE881640L (en) 1988-12-01
NO169900C (no) 1992-08-19
BG60429B2 (bg) 1995-03-31
CN1022184C (zh) 1993-09-22
KR970000952B1 (ko) 1997-01-21
HU211482A9 (en) 1995-11-28
DK295288D0 (da) 1988-05-31
EP0293978B1 (en) 1993-09-15
LV10452B (en) 1995-08-20
CN88103408A (zh) 1988-12-14
PT87623B (pt) 1992-09-30
EP0293978A3 (en) 1990-06-13
PT87623A (pt) 1988-06-01
KR890000469A (ko) 1989-03-14
RU1838308C (ru) 1993-08-30
CA1307271C (en) 1992-09-08
NO882390D0 (no) 1988-05-31
FI882552A (fi) 1988-12-02
FI882552A0 (fi) 1988-05-31
LTIP1625A (en) 1995-07-25
NO882390L (no) 1988-12-02
IE61823B1 (en) 1994-11-30
HU201056B (en) 1990-09-28
DE3884055T2 (de) 1994-01-27
NO169900B (no) 1992-05-11
JPS63316775A (ja) 1988-12-26
LT3950B (en) 1996-05-27
NZ224714A (en) 1990-03-27
AU603446B2 (en) 1990-11-15
CY1866A (en) 1988-05-26
HK114795A (en) 1995-07-21
LV10452A (lv) 1995-02-20
FI90078B (fi) 1993-09-15
ES2059490T3 (es) 1994-11-16
HUT49132A (en) 1989-08-28
ZA883861B (en) 1990-01-31
IL86551A0 (en) 1988-11-15
IL86551A (en) 1992-07-15
EP0293978A2 (en) 1988-12-07
JPH0662612B2 (ja) 1994-08-17
FI90078C (fi) 1993-12-27
DK295288A (da) 1988-12-02

Similar Documents

Publication Publication Date Title
BG50278A3 (bg) Метод за получаване на (1н-азол-1-илметил)-заместени бензотриазолови производни
FI94340C (fi) Menetelmä farmakologisesti vaikuttavien 1,5-diaryyli-3-(w-substituoitu-alempi-alkyyli)-pyratsolien valmistamiseksi
BG46598A3 (bg) Метод за получаване на алфа-хетероциклично заместени толунитрили
PT68573A (fr) Procede de preparation des derivatifs d'imidazole.
BG41130A3 (bg) Метод за получаване на 8-хлор-1,5-бензо-тиазепинови производни
FI884626A0 (fi) Menetelmä terapeuttisesti käyttökelpoisen 4H-1-bentsopyran-4-onijohdoksen tai sen suolan valmistamiseksi ja menetelmässä käyttökelpoinen välituote
PT80157B (en) Methods of treating viral diseases with pyridazinamines anti-virally active pyridazinamines
ES8606336A1 (es) Un procedimiento para la preparacion de derivados de tiazol 2,4-disustituidos
ATE74003T1 (de) Waessriges pharmazeutisches praeparat.
GR900100380A (el) Μέ?οδος παρασκευής αντι-φλεγμονωδών παραγώγων αμινοφενόλης.
ES525786A0 (es) Un procedimiento para preparar derivados de pirazolo (3,4-b) piridina
DE3873197D1 (de) Leitungsmetallisierung von substraten mittels entwicklungsmittel.
ES8304919A1 (es) Un procedimiento para la preparacion de dicloroamino-acidos.
ES482420A1 (es) Un procedimiento para la preparacion de 4-desoxi-4-acilamino-derivados de eritromicilamina.
ES2016464A6 (es) Procedimiento para preparar derivados de 2', 5' -oligoadenilato.
IT7926964A0 (it) Procedimento per la produzione di derivati dell'acido fenossicarbossilico.
ES478874A1 (es) Procedimiento de preparar 3-0(beta -d-glucuronopiranosil)- soja-sapogenol b.
ES8307249A1 (es) Procedimiento de preparacion de nuevos derivados del adamantano.
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
ES2074178T3 (es) Preparados de antimicoticos externos de imidazol.
FI93216C (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1,3-dioksaanialkeenihappojohdannaisten valmistamiseksi
ES8301948A1 (es) "procedimiento para la preparacion de 3-hidroxi-1,2,4-triazoles".
BG40653A3 (bg) Метод за получаване на амидотиолкарбаматни производни на карбоновата киселина
BG39977A3 (bg) Метод за получаване напроизводни на фурилоксазолил- оцетна киселина
GR1001566B (el) Μέ?οδος παρασκευής νέων παραγώγων βενζοφουρανυλιμιδαζόλης.